Haemonetics Corporation (NYSE:HAE) is looking for acquisitions. Chris Simon, President and Chief Executive Officer, said "we will continue to pursue inorganic growth by building our capabilities for programmatic M&A. Over the last 2 years, we have completed 4 acquisitions, each exceeding their expected impact in terms of additional growth and return on investment. We are committed to continued portfolio evolution, and we will seek additional opportunities to align our portfolio to the strategy of winning markets, leading positions and superior returns".